A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer
研究单位：[1]Shandong Cancer Hospital & Institute-department[2]Jilin Provincial Tumor Hospital[3]Shanghai Henlius Biotech[4]OPN-Glendale,Arcadia,California,United States,91007[5]OPN-Los Alamitos,Los Alamitos,California,United States,90720[6]Southern California Permanente Group,Los Angeles,California,United States,90034[7]Emad Ibrahim, MD, Inc,Redlands,California,United States,92373[8]Providence Medical Foundation,Santa Rosa,California,United States,95403[9]Lutheran Medical Center - Cancer Centers of Colorado,Golden,Colorado,United States,80401[10]Eastern Connecticut Hematology & Oncology Associates,Norwich,Connecticut,United States,06360[11]Cancer Specialists of North Florida,Jacksonville,Florida,United States,32257[12]Mid Florida Hematology and Oncology Center,Orange City,Florida,United States,32763[13]Advent Health Orlando,Orlando,Florida,United States,32804[14]Napa Research,Pompano Beach,Florida,United States,33064[15]Kansas University Mediacal Center,Fairway,Kansas,United States,66205[16]Pontchartrain Cancer Center,Covington,Louisiana,United States,70433[17]Tulane University,New Orleans,Louisiana,United States,70112[18]Health Partners,Bloomington,Minnesota,United States,55425[19]Renown Health,Reno,Nevada,United States,89502[20]Dartmouth Hitchcock Medical Center,Lebanon,New Hampshire,United States,03756[21]Montefiore Medical Center,Bronx,New York,United States,10467[22]New York City Health+HospitalsCorporation Elmhurst Hospital Center,Elmhurst,New York,United States,11373[23]Northwell Health,Queens,New York,United States,11040[24]Cleveland Clinic Mercy Hospital,Canton,Ohio,United States,44708[25]Gabrail Cancer Center,Canton,Ohio,United States,44718[26]Tricounty Hematology and Oncology Associates,Massillon,Ohio,United States,44646[27]Kaiser Permanente Northwest,Portland,Oregon,United States,97229[28]The Center for Cancer and Blood Disorders,Fort Worth,Texas,United States,76104[29]Millennium Research & Clinical Development,Houston,Texas,United States,77090[30]Pro Research Tools, INC DBA Lumi Research,Kingwood,Texas,United States,77339[31]The University of Texas - Hope Cancer Center,Tyler,Texas,United States,75701[32]Innova Schar Cancer Insitute,Fairfax,Virginia,United States,22031[33]Northwest Medical Specialties,Tacoma,Washington,United States,98405[34]Klinikum Klagenfurt am Worthersee,Klagenfurt am Worthersee,Austria,9020[35]Klinikum Klagenfurt am Wörthersee,Klagenfurt am Wörthersee,Austria,9020[36]Karl Landsteiner Institut für Lungenforschung und pneumologische Onkologie, c/o Klinik Floridsdorf Abteilung für Innere Medizin und Pneumologie,Wien,Austria,1210[37]Karl Landsteiner Institute for Lung Research and Pneumological Oncology, c/o Klinik Floridsdorf Department for Inner Medicine und Pneumology,Wien,Austria,1210[38]The First Affiliated Hospital of Bengbu Medical College,Bengbu,Anhui,China,233099[39]Anhui Chest Hospital,Hefei,Anhui,China,230031[40]Cancer Hospital Chinese Academy of Medical Sciences,Beijing,Beijing,China,100021[41]Beijing Cancer Hospital,Beijing,Beijing,China,100142[42]The First Affiliated Hospital of Chongqing Medical,Chongqing,Chongqing,China,400016[43]Chongqing University Cancer Hospital,Chongqing,Chongqing,China,400030[44]Fujian Cancer Hospital,Fuzhou,Fujian,China,350011[45]The First Affiliated Hospital of Guangdong Pharmaceutical University,Guangzhou,Guangdong,China,510000[46]Sun Yat-Sen University Cancer Center,Guangzhou,Guangdong,China,510030[47]Peking University Shenzhen Hospital,Shenzhen,Guangdong,China,518036[48]The Second Affiliated Hospital of Guilin Medical University,Guilin,Guangxi,China,541100[49]Guangxi Medical University Cancer Hospital,Nanning,Guangxi,China,530021[50]Gungzhouyikedaxuefushuzhongliuyiyuan,Guangzhou,Guangzhou,China,510095[51]Affiliated Hospital of Hebei University,Baoding,Hebei,China,071000[52]Cangzhou People's Hospital,Cangzhou,Hebei,China,061019[53]Tangshan People's Hospital,Tangshan,Hebei,China,063001[54]Harbin Medical University Cancer Hospital,Harbin,Heilongjiang,China,150000[55]Jiamusi Cancer Hospital,Jiamusi,Heilongjiang,China,154007
This study is a randomized, double-blind, multicenter, phase III clinical study to compare the clinical efficacy and safety of Serplulimab + chemotherapy+ concurrent radiotherapy vs chemotherapy+ concurrent radiotherapy in subjects with Limited-Stage Small Cell Lung Cancer.
